Announcing our $19,8 million Series A round. Read more here.

European Heart Rhythm Association Awards Gold Medal to Iker Casillas

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022.

Idoven's AI platform, a key ally for ICMs to improve arrhythmia and false positive detection.

Jose María Lillo Castellano

AstraZeneca and Idoven are using Artificial Intelligence to diagnose cardiovascular diseases through a pioneering project in Europe

#WorldHeartDay - An interview with María de la Parte, Pediatric cardiologist at Idoven

Blog

1

5

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022.

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022

Idoven's AI platform, a key ally for ICMs to improve arrhythmia and false positive detection.

Idoven's AI platform improves arrhythmia and false positive detection on ICM Confirm RxTM Abbott

AstraZeneca and Idoven are using Artificial Intelligence to diagnose cardiovascular diseases through a pioneering project in Europe

AstraZeneca and Idoven are using Artificial Intelligence to diagnose heart failure through a pioneering project in Europe

September is atrial fibrillation awareness month

Atrial fibrillation, an increasing epidemic

European Heart Rhythm Association Awards Gold Medal to Footballer Iker Casillas

European Heart Rhythm Association Awards Gold Medal to Iker Casillas

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022

Science & Technology

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022.

Idoven's AI platform improves arrhythmia and false positive detection on ICM Confirm RxTM Abbott

Science & Technology

Idoven's AI platform, a key ally for ICMs to improve arrhythmia and false positive detection.

AstraZeneca and Idoven are using Artificial Intelligence to diagnose heart failure through a pioneering project in Europe

AstraZeneca and Idoven are using Artificial Intelligence to diagnose cardiovascular diseases through a pioneering project in Europe

#WorldHeartDay - An interview with María de la Parte, Pediatric cardiologist at Idoven

#WorldHeartDay - An interview with María de la Parte, Pediatric cardiologist at Idoven

Atrial fibrillation, an increasing epidemic

September is atrial fibrillation awareness month